Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

1

1 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

1 companies

Hypera

Market Cap: R$14.8b

Operates as a pharmaceutical company in Brazil.

New

HYPE3

R$21.06

7D

4.1%

1Y

-18.4%